CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 65 filers reported holding CORVUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $72,000 | +35.8% | 14,949 | -24.3% | 0.01% | -44.4% |
| Q2 2021 | $53,000 | -59.8% | 19,737 | -53.9% | 0.02% | -57.1% |
| Q1 2021 | $132,000 | +140.0% | 42,857 | +177.1% | 0.04% | +162.5% |
| Q4 2020 | $55,000 | +22.2% | 15,467 | +37.5% | 0.02% | +14.3% |
| Q3 2020 | $45,000 | +25.0% | 11,247 | -33.6% | 0.01% | -6.7% |
| Q1 2020 | $36,000 | – | 16,947 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $7,501,161 | 1.96% |
| TOWERVIEW LLC | 205,000 | $469,450 | 0.31% |
| Orbimed Advisors | 6,943,654 | $15,900,968 | 0.29% |
| CHI Advisors LLC | 200,000 | $458,000 | 0.14% |
| BVF INC/IL | 1,370,947 | $3,139,469 | 0.09% |
| SAMLYN CAPITAL, LLC | 2,105,930 | $4,822,580 | 0.08% |
| MYDA Advisors LLC | 100,000 | $229,000 | 0.07% |
| DIFESA CAPITAL MANAGEMENT, LP | 10,000 | $22,900 | 0.06% |
| JACKSON SQUARE CAPITAL, LLC | 63,773 | $146,040 | 0.06% |
| CORNERCAP INVESTMENT COUNSEL INC | 97,248 | $222,698 | 0.04% |